InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,157.83
(
0.59%
)
US TECH 100
17,520.85
(
0.58%
)
Dow Jones
38,762.62
(
0.22%
)
Brent Oil
83.30
(
0.20%
)
Bitcoin
62,963.17
(
-1.62%
)

Replies to post #890 on Enanta Pharmaceuticals Inc (ENTA)

Replies to #890 on Enanta Pharmaceuticals Inc (ENTA)

DewDiligence

02/13/15 11:24 AM

#891 RE: pollyvonwog #890

It’s a competitive advantage for ABBV to not have V-Pak prescriptions publicly disclosed. In that way, ABBV sees the whole (US) market while GILD sees only part of it.